Developing innovative ADCs, bi-specific, and multi-specific antibodies for cancer treatment
Targeting multiple signaling pathways to overcome insufficient anti-tumor responses
Description
Biokin is a clinical-stage company developing innovative ADCs, bi-specific, and multi-specific antibodies for the treatment of cancers. By targeting multiple signaling pathways, Biokin is seeking to overcome the insufficient anti-tumor responses typical of existing mono-antibody therapies.
Reviews
Reviews here come from delivered orders. Only buyers who completed a delivered order can rate this supplier, so the first review appears after the first delivery on BharatSeal.
Questions & answers
Ask the supplier. Answers are visible to all buyers
No questions yet. Ask the first one: the supplier is notified and the answer is posted here for every buyer.